Clinical Trial Update: Adjunct Episcleral Brachytherapy for PCV [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for adjunct episcleral brachytherapy in polypoidal choroidal vasculopathy and age-related macular degeneration, currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Adjunct Episcleral Brachytherapy

Snippet

Sponsor: Salutaris Medical Devices, Inc. | Conditions: Age-Related Macular Degeneration, Polypoid Choroidal Vasculopathy | Phase 3 | Status: NOT_YET_RECRUITING